x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization. Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist

science life sciences

All Episodes

22:53

Molecule to Market: Our top trends 2023; part 2

Molecule to Market: Inside the outsourcing space ·

2024/01/19

In this special end-of-year episode, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who reflects on the 50+ episodes and special guest interviews throughout 2023. In the second part of our series on the top trends 2023, we dive deep into the dynamic and ever-evolving life sciences sector. From its various life cycles to the winds of change shaping the industry in 2024, there is a positive upturn on the horizon. In part two of the top

en

40:40

Outsourcing in Ontario - on the cusp of greatness

Molecule to Market: Inside the outsourcing space ·

2024/01/12

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jason Field, President & CEO of Lifesciences Ontario. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jason, covering: How the combination of his scientific background and his passion for public policy made him a perfect fit for Lifesciences Ontario (LSO) How the pandemic acted as a wake-up call and catalyst to kickstarting a

en

48:30

Discover Diana of Dalriada

Molecule to Market: Inside the outsourcing space ·

2024/01/05

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Diana Kraskouskaya, co-founder and CEO of Dalriada Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Diana, covering: Exactly what ‘the Toronto paradox’ is... How two, seed-funded failures, led to identifying a gap in the market along with access to a rich talent pool The challenges and realities of starting, growing and scaling a CRO

en

25:15

Molecule to Market: Our top trends 2023, part 1

Molecule to Market: Inside the outsourcing space ·

2023/12/29

In this special end-of-year episode, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who reflects on the 50+ episodes and special guest interviews throughout 2023. This special episode covers five key trends Raman identified including: The biotech slowdown in 2023 and how it affected the biotech sponsor space Covid rebalancing and the macro-factors that have affected the sector A continued focus on the life sciences supply chain -

en

29:05

Expert to Entrepreneur

Molecule to Market: Inside the outsourcing space ·

2023/12/15

In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeffrey P. Kiplinger, Partner at Selling Science. Your host, Raman Sehgal, sits down with Jeff to discuss his new book, 'Expert to Entrepreneur'. Jeff Kiplinger is a PhD chemist who, after leaving a scientific leadership role at Pfizer in 1998, transitioned to business leadership and an entrepreneurial track. In 2007 he founded Averica Discovery, an analytical drug

en

45:06

The lab model of the future?

Molecule to Market: Inside the outsourcing space ·

2023/12/08

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Clement Fourny, SVP of Commercial at SmartLabs. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Clement, covering: His journey of exploring options and opportunities, which led him to the life sciences space at just the right time Why modular labs and manufacturing suites as a service could provide a de-risked and cost-effective solution

en

49:37

Look into 2024: Events Roundtable special

Molecule to Market: Inside the outsourcing space ·

2023/12/01

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: Manuel Leal, Corporate Marketing Director at Ardena. Eden Turner, Senior Conference Producer at Informa Connect Life Sciences Catherine Hunter, Senior Commercial Manager at ramarketing Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology outsourcing events space, covering: How industry events are experiencing record numbers in a post-pandemic world The role

en

48:21

The problem-solving CMC consultant

Molecule to Market: Inside the outsourcing space ·

2023/11/24

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kevin Bittorf, Founder and Principal Consultant of SCxCMC. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kevin, covering: Joining a little company called Vertex Pharma when it was looking to be innovative The leap of faith required to become a consultant, and why helping smaller businesses makes a bigger difference An insight into the

en

47:37

Microsoft talks to Molecule to Market

Molecule to Market: Inside the outsourcing space ·

2023/11/17

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dr. Andi White, Head of Business Operations & Strategy for the Healthcare Industry Solutions Accelerator at Microsoft. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Andi, covering: How five years at GE helped develop and shape Andi into a leader Why having a broad mindset early on in your career will help you flourish down the

en

47:36

Biopharma innovation in motion

Molecule to Market: Inside the outsourcing space ·

2023/11/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Charles Ruban, CEO at Verdot. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Charles, covering: Crossing the border from supply chain to R&D, lessons learned from a technician turned business leader Creating the most extensive peanut allergy clinical trial in the world and opting for an IPO instead of a big pharma licensing deal How a

en

45:30

Say hello to a “CTDMO”

Molecule to Market: Inside the outsourcing space ·

2023/11/03

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dirk Lange, Head of Life Science Services at MilliporeSigma. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Dirk, covering: What he has learned from 25 years of bouncing around geographically in terms of cultural differences in understanding clients and colleagues Life on both sides of the fence as a drug sponsor and a CDMO, including key

en

47:18

The involuntary entrepreneur chemist

Molecule to Market: Inside the outsourcing space ·

2023/10/27

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Fredrik Lehmann, Venture Partner at Industrifonden. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Fredrik, covering: How the closing of a business and customer requests led to a phoenix from the flames start-up opportunity His company's journey from inception and growth to eventual sale to Recipharm His transition to becoming a VC

en

45:40

A passion for pharma packaging

Molecule to Market: Inside the outsourcing space ·

2023/10/20

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter Belden, President of Tjoapack US. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering: How the success of a contract packaging operation led to a divestiture from AmerisourceBergen to PCI The fun, games, and complexities of multi-national, M&A integrations Smaller patient populations and personalized

en

07:37

M2M meets Moderna & CPHI Conversations

Molecule to Market: Inside the outsourcing space ·

2023/10/17

In this episode of Molecule to Market, tune in for a special announcement about where to find Molecule to Market host, Raman Sehgal, at CPHI Barcelona this month. Listen to the short episode covering: CDMO outlook - the trends and developments Raman expects to see this year and into 2024 A fireside chat with Moderna covering COVID-19 and Oncology Panel moderation on the topic - Why building a collaborative network is essential Are you heading to CPHI this month? Stop by one of Raman’s panels to

en

48:43

Launching a technology-forward CDMO

Molecule to Market: Inside the outsourcing space ·

2023/10/13

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Bruce Thompson, CEO of Kincell Bio. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Bruce, covering: The daunting and exciting prospect of launching a CDMO spin-out focused on early-phase companies The challenges and opportunities of pivoting a facility from innovator-owned to CDMO-owned Navigating from technical leader to a first CEO

en

47:23

Designing facilities today for tomorrow’s medicines

Molecule to Market: Inside the outsourcing space ·

2023/10/06

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gordon Nicholson, Director of the Life Sciences NEA at Exyte. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gordon, covering: Transitioning from a regular, technical role into a commercial lead in Asia Lessons from sport and going back to basics when breaking down silos at Novo Nordisk Engineering Tips for building a presence and doing

en

51:07

The problem-solving biopharma veteran

Molecule to Market: Inside the outsourcing space ·

2023/09/29

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Matthew Stober, Chief Executive Officer at Abzena. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Matt, covering: How the failure of a big pharma R&D portfolio led to the creation of a CDMO business and a pipeline-ready facility Leadership lessons for transitioning from a functional leader to an enterprise-level one, and being part of

en

51:48

The servant leader creating the next generation CDMO

Molecule to Market: Inside the outsourcing space ·

2023/09/22

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with J.D. Mowery, President and Chief Executive Officer at KBI Biopharma. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with J.D., covering: The experience of bringing a product to market... and then many years later seeing that product used on his wife to help bring his sons into the world How bringing a commercial facility online for Genentech

en

49:23

From Powdersize to Microsize

Molecule to Market: Inside the outsourcing space ·

2023/09/15

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with TJ Higley, CEO at Microsize. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with TJ, covering: The fast, easy, scalable, precise, and non-patent-protected benefits of micronization How a synergistic capability alliance led to the eventual sale of his business to Lonza Capsugel The risks and realities of being an entrepreneur acquiring an

en

39:10

The mission-driven biotech CEO

Molecule to Market: Inside the outsourcing space ·

2023/09/08

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Howard Berman, CEO and Chairman of the Board at Coya Therapeutics Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Howard, covering: How a neurology appointment with his father led to the creation of a biotech company focused on neurodegenerative, autoimmune, and metabolic diseases Having the DNA of an entrepreneur but taking the time to

en

256 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter